Now a part of the Veranex family
IMMR’s unique, highly efficient, and full-service approach saves money and reduces time to market.
IMMR stood as one of the most efficient and well-rounded preclinical science organizations, providing preclinical research, pathology evaluation and surgical training services to medical technology innovators. Located in Paris, France – it also further expanded Veranex’s global footprint. IMMR exceled in procedures ranging from early feasibility studies through to GLP studies to support global regulatory approvals, with an expert team of professionals that produced high success rates.
Through the acquisition of IMMR, Veranex gained state-of-the-art, FDA-inspected and AAALAC-acredited facilities and extensive in-house expertise, enhancing Veranex’s services for preclinical studies worldwide. Veranex’s clients benefit from IMMR’s 30 plus years of experience in the design and conduct of preclinical studies, expertise in complex cardiovascular and non-cardiovascular procedures, and state-of-the art surgical suites and husbandry facilities, all unparalleled for leading successful completion of sophisticated studies with novel interventional or surgical technologies.